Rutgers Cancer Institute of New Jersey Clinical Leader Recognized as Fellow of the American Society of Radiation Oncology

Dr. Salma Jabbour has been named a Fellow of the American Society of Radiation Oncology (FASTRO). This distinction honors individuals who have made significant contributions to the society and to the field of radiation oncology through research, education, patient care and service to the field.

Protecting your Heart Before, During and After Cancer Treatment

Therapies such as chemotherapy, radiotherapy, immunotherapy and other novel targeted treatments that are used to combat many cancers have the potential to contribute to cardiac toxicity. Rutgers Cancer Institute expert sheds light on the field of Cardo-Oncology, which focuses on the prevention and treatment of cardiac-related issues in cancer patients.

Rutgers Cancer Institute of New Jersey and RWJBarnabas Health Leader Recognized as NJBIZ 2021 Healthcare Hero

Rutgers Cancer Institute of New Jersey Director Steven K. Libutti, MD, FACS, who is also senior vice president of oncology services at RWJBarnabas Health and vice chancellor for cancer programs for Rutgers Biomedical and Health Sciences, has been named by the business journal NJBIZ as a 2021 Healthcare Hero in the healthcare professional category.

Experts from Rutgers Cancer Institute of New Jersey Comment on Lifestyle Changes for Cancer Prevention

New Brunswick, N.J., June 28, 2021 – According to the American Cancer Society, cancer is the second leading cause of death among Americans. Researchers believe that one way to decrease the risk of developing cancer is adopting a healthy lifestyle.…

RWJBarnabas Health and Rutgers Cancer Institute of New Jersey Break Ground on Jack & Sheryl Morris Cancer Center

RWJBarnabas Health and Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, in partnership with the New Brunswick Development Corporation (DEVCO), broke ground on the state’s first freestanding cancer hospital.

Rutgers Cancer Institute of New Jersey Experts Available for Comment during Men’s Health Month

New Brunswick, N.J., June 7, 2021 – June is a special time of year focused on heightening the awareness of preventable health problems and encouraging early detection and treatment of disease for men. Diseases like prostate cancer, which is the…

Pride, Progress and Breaking down Barriers: LGBTQ+ Cancer Concerns

A person with cancer who identifies as lesbian, gay, bisexual, transgender or non-binary may have unique concerns about communicating with their cancer care team, navigating the healthcare system and coping with their diagnosis. An expert from Rutgers Cancer Institute calls attention to the healthcare challenges and barriers faced by this community during Pride Month and explains how health care professionals are becoming better allies.

Rutgers Cancer Institute of New Jersey and RWJBarnabas Health to Present Extensive, Wide-Ranging New Cancer Research Data at the 2021 ASCO Annual Meeting

Rutgers Cancer Institute of New Jersey, a leader in cutting-edge clinical trials and health outcomes analyses and a designated Comprehensive Cancer Center by the National Cancer Institute, together with RWJBarnabas Health, today announced that data from its cancer clinical research program will be presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held virtually from June 4-8.

The Unique Role of the Oncology Nurse: Lifelong Learning, Healing and Helping

Oncology nursing is a unique specialty that requires specific knowledge of the biological and psychosocial dimensions of cancer and its effects on individuals and families. Oncology nurse at Rutgers Cancer Institute of New Jersey shares more on the role of oncology nurses and the importance of the oncology nurse certification.

The Greatest Gift for Mom: Health and Wellness

Now more than ever, we are reminded that health and wellness should always be a top priority. National Women’s Health Month and Mother’s Day, both celebrated in May, are important reminders that women can take control of their health by making feasible lifestyle choices and focusing on preventive care to lower the risk of certain cancers.

What is Bladder Cancer?

The bladder, a part of the urinary system, is a hollow organ in the pelvis with the primary function of storing and then eliminating urine that drains into it from the kidney. Cancer of the bladder develops when abnormal cells in the bladder start to grow out of control. Rutgers Cancer Institute expert explains what you need to know.

Rutgers Cancer Institute of New Jersey Experts Available for Comment on Research Topics during National Cancer Research Month

New Brunswick, N.J., April 29, 2021 – Many years of research devoted to cancer has led to valuable insight and life-saving measures. To highlight the importance of lifesaving research to the millions of people around the world impacted by cancer,…

Experts from Rutgers Cancer Institute of New Jersey Comment on Skin Cancer and Sun Protection

New Brunswick, N.J., April 29, 2021 – According to the National Cancer Institute (NCI), skin cancer is the most common type of cancer. While we all want to enjoy the outdoors, increased exposure to ultraviolet (UV) rays from the sun…

Rutgers Cancer Institute of New Jersey Leader Elected as a Member to the National Academy of Sciences

Rutgers Cancer Institute of New Jersey Deputy Director, Chief Scientific Officer, and Associate Director for Basic Research Eileen White, PhD, has been elected to the National Academy of Sciences (NAS). She is among 120 members elected this year in recognition of their distinguished and continuing achievements in original research.

Rutgers Cancer Institute of New Jersey Clinical Leader Recognized as Fellow of the American Society of Clinical Oncology

Rutgers Cancer Institute of New Jersey Associate Chief of Urology and Urologic Oncology and Director of the Kidney Cancer Program Eric A. Singer, MD, MA, MS, FACS, has been named a Fellow of the American Society of Clinical Oncology (FASCO). This distinction honors members for their extraordinary volunteer service and dedication to the American Society of Clinical Oncology (ASCO).

Exploring PD-L1 Expression in Malignant Peritoneal Mesothelioma

In a recent study from Rutgers Cancer Institute of New Jersey, researchers tested whether or not mesothelioma cancer cells express high amounts of PD-L1, a protein that is abundantly present on some types of cancer cells. The PD-L1 protein is an inhibitory molecule that binds to the PD-1 receptor on T-cells, which are cells known to have the ability to recognize and destroy cancer cells in the body. Results of the work are being shared as a poster presentation at the Society of Surgical Oncology 2021 International Conference on Surgical Cancer Care virtual meeting.

Negligible Detection of SARS-CoV2 found in Environmental Surface Testing of Hematology/Oncology Inpatient and Outpatient Settings

Researchers from Rutgers Cancer Institute of New Jersey evaluated the frequency of SARS-CoV-2, the virus that causes COVID-19, on various environmental surfaces in outpatient and inpatient hematology/oncology settings located within Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility. The study, published in Cancer, revealed extremely low detection of SARS-CoV-2 on environmental surfaces across multiple outpatient and inpatient oncology areas, including an active COVID-19 floor.

Exploring Impact of Surgery Delays for Clinical Renal Cell Carcinoma Patients during the COVID-19 Pandemic

During the peak of the COVID-19 pandemic, several elective surgeries for renal cell carcinoma, the most common type of kidney cancer, were delayed with unknown impact on outcomes for patients. Researchers at Rutgers Cancer Institute of New Jersey explored the impact of surgery delays for these patients throughout the United States by utilizing the National Cancer Database to explore outcomes of patients who underwent surgery up to and after three months post diagnosis.

Gynecologic Oncology Leader Named at New Jersey’s Only NCI-designated Comprehensive Cancer Center

Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital (RWJUH), a RWJBarnabas Health facility, have named James K. Aikins, Jr., MD, FACOG, FACS chief of gynecologic oncology at Rutgers Cancer Institute and chief of gynecologic oncology services at RWJUH, New Jersey’s largest academic medical center.

Our Role in Beating Cancer Together in New Jersey and Beyond

This year’s theme for World Cancer Day 2021 — “Together, all our actions matter” — calls for individuals to reflect on the idea that collaboration and collective action make us stronger in the fight against cancer and spreads the powerful message that we all have a role to play in reducing the global impact of the disease. At Rutgers Cancer Institute of New Jersey in partnership with RWJBaranabas Health, experts are always working toward the goal of helping individuals fight cancer through onsite research, clinical trials and collaborations with teams locally and across the globe. Learn more about how.

First Patient Recently Treated with New Non-Surgical Therapy for Urothelial Cancer at Rutgers Cancer Institute

Upper tract urothelial cancer (UTUC) is a subset of urothelial cancer that is found in the renal pelvis or the ureter, part of the genitourinary tract. Surgery has remained the mainstay of treatment for this type of cancer, until last year, when the U.S. Food and Drug Administration (FDA) approved mitomycin gel as the first non-surgical therapy option to treat this type of cancer. Rutgers Cancer Institute of New Jersey has recently treated its first UTUC patient with this new therapy.

Environmental Surface Testing in Inpatient and Outpatient Hematology/Oncology Settings Shows Negligible Detection of SARS-CoV2

Researchers from Rutgers Cancer Institute of New Jersey evaluated the frequency of SARS-CoV-2, the virus that causes COVID-19, on various environmental surfaces in outpatient and inpatient hematology/oncology settings located within Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility. The study revealed extremely low detection of SARS-CoV-2 on environmental surfaces across multiple outpatient and inpatient oncology areas, including an active COVID-19 floor.

Rutgers, RWJBarnabas Health Host Global Neurosurgery Symposium

At 3 a.m. in early September, when most people were still in their beds, more than 400 viewers in China were logged in to a special broadcast, translated in Chinese, focused on neuro-tech and global neurosurgery issues. They were among the thousands of neurosurgeons, residents, medical students and other professionals who tuned in each day to a massive, three-day Global Neurosurgery symposium in September, “Global Neurosurgery: Ask Not for Whom the Bell Tolls.”

What Does it Mean to be An NCI-Designated Comprehensive Cancer Center?

Rutgers Cancer Institute is a National Cancer Institute-designated Comprehensive Cancer Center, a designation reserved for those cancer centers who meet the highest of standards in research, treatment, prevention and education. Rutgers Cancer Institute expert explains why this distinction sets Rutgers Cancer Institute and RWJBarnabas Health apart.

Surgery Milestone Reached for Rutgers Cancer Institute Urologic Oncology Leader at Robert Wood Johnson University Hospital

Rutgers Cancer Institute of New Jersey Urologic Oncology chief marks a major milestone in completing his 2,000th robotic prostatectomy at Robert Wood Johnson University Hospital, an RWJBarnabas Health facility and one of the few hospitals in the state designated to teach surgeons about this technique.

New Rutgers Saliva Test for Coronavirus Gets FDA Approval

The FDA has granted emergency use authorization (EUA) to Rutgers’ RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus, the first such approval granted by the federal agency. The new saliva collection method, which RUCDR developed in partnership with Spectrum Solutions and Accurate Diagnostic Labs (ADL), will allow for broader population screening than the current method of nose and throat swabs.